Certara Inc (NAS:CERT)
$ 13.29 0.29 (2.23%) Market Cap: 2.14 Bil Enterprise Value: 2.22 Bil PE Ratio: 0 PB Ratio: 2.05 GF Score: 83/100

Certara Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 03:45PM GMT
Release Date Price: $15.51 (-6.17%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

All right. Let's go ahead and get started. Thanks for joining everyone. This is the fireside chat with Certara. My name is Vikram Purohit. I'm one of the biotech analysts with Morgan Stanley Research. Happy to have with me CEO, Bill Feehery; and CFO, Andy Schemick. Bill, Andy, thanks for joining us.

Before we get started, I need to read a brief disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

With that, Bill, Andy, why don't we start with some opening remarks. Maybe you could just talk a bit about what biosimulation is and how Certara is involved with the space for those in the audience that may not be fully familiar with the story.

William F. Feehery
Certara, Inc. - CEO & Director

Great. Thanks,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot